Loghin, Effects of renal impairment on the pharmacokinetics of the dual GIP and GLP-1 receptor agonist tirzepatide
What should I do if I have concerns about my semaglutide medication
Last Updated: April 4, 2026 | Reading Time: Approximately 8 minutes | Author: Palmetto Peptides Research Team Quick Answer When researchers move beyond native IGF-1 and begin evaluating synthetic analogs for preclinical work, two peptides come up consistently: IGF-1 LR3 and IGF-1 DES
Social skills groups that include typically developing children have the most research support
Scott TL, Wicker CA, Suganya R, Dhar B, Pittman T, Horbinski C, et al
10.1038/nm1233 175 Skrzyska-DziduszkoK